Type in product code or name:
Code | Name | Applications | Availability | Size | Tested species | Price | Grade | |
---|---|---|---|---|---|---|---|---|
EB06964 | Goat Anti-HEXIM1 Antibody | Pep-ELISA, WB, IF | 100µg specific antibody in 200µl | Human, Mouse | $411.00 | |||
Ordering Information forOrder direct from Everest
$73.00: Overnight shipping to United States of America
Sent via overnight courier arrives approximately next day to mainland USA. Please note that your order will be shipped by our parent company Vector Laboratories. Order offline99% of products are held in stock for immediate shipment, see individual product pages for availability. Please order through the US Dollar shopping cart (links on each product page) or we accept orders by email ([email protected]) Please include the following information with your order:
In stock orders received by 11 am PST on Monday through Friday are shipped the same day. Orders are shipped by our parent company Vector Laboratories, 6737 Mowry Avenue, Newark CA 94560, USA. |
Peptide with sequence C-HRQQERAPLSKFGD, from the C Terminus of the protein sequence according to NP_006451.1.
Please note the peptide is available for sale.
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20°C. Minimize freezing and thawing.
Immunofluorescence: Strong expression of the protein seen in the nucleus of A431 and HeLa cells. Recommended concentration: 10µg/ml.
This antibody has been successfully used in Western blot on Human:
Salla Kyheröinen et al.
Actin associates with actively elongating genes and binds directly to the Cdk9 subunit of P-TEFb.
J Biol Chem. 2024 Mar;300(3):105698.
PMID: 38301887
This antibody has been successfully used in the following paper:
Zhijia Wang, Samu V. Himanen, Heidi M. Haikala, Caroline C. Friedel, Anniina Vihervaara, Matjaž Barborič
Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release
(2023) https://doi.org/10.1101/2023.03.21.533608
PMID: 0
This antibody (previous batch) has been successfully used in IP on Human:
Andrii Bugai, Alexandre J.C. Quaresma, Caroline C. Friedel, Tina Lenasi, Christopher R. Sibley, Petra Kukanja, Koh Fujinaga, Melanie Blasius, Thomas Hennig, Jernej Ule, Lars Dölken, Matjaz Barboric
P-TEFb activation by RBM7 shapes a pro-survival transcriptional response to genotoxic stress
Mol Cell. 2019 Apr 18;74(2):254-267.e10.
PMID: 30824372
This antibody (previous batch) has been successfully used in Western blot on Human:
Dalibor Blazek, Fernando Teque, Carl Mackewicz, Matija Peterlin and Jay A. Levy.
The CD8+ cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+ cells.
J Gen Virol. 2016 Jan;97(1):220-4.
PMID: 26499373